Literature DB >> 15636696

Hemophagocytic lymphohistiocytosis after chemotherapy for multiple myeloma.

John V Terrovitis1, Charis Matsouka, Athanassios Anagnostopoulos, Maria I Anastasiou-Nana, Athanassios Meletios Dimopoulos.   

Abstract

Secondary hemophagocytic lymphohistiocytosis has been reported after infections in immunocompromised hosts or in association with several malignancies. We report a case of secondary hemophagocytic syndrome after chemotherapy for multiple myeloma, which responded dramatically to dexamethasone, etoposide, and cyclosporin A.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15636696     DOI： 10.3816/clm.2004.n.026

Source DB:  PubMed          Journal:  Clin Lymphoma        ISSN： 1526-9655


  4 in total

Review 1.  Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma.

Authors:  Maciej Machaczka; Johan Vaktnäs; Monika Klimkowska; Hareth Nahi; Hans Hägglund
Journal:  Med Oncol       Date:  2010-04-01       Impact factor: 3.064

Review 2.  Mechanistic Insights in Hemophagocytic Lymphohistiocytosis: Subsequent Acute Hepatic Failure in a Multiple Myeloma Patient Following Therapy with Ixazomib-Lenalidomide-Dexamethasone.

Authors:  Catalin Constantinescu; Bobe Petrushev; Ioana Rus; Horia Stefanescu; Otilia Frasinariu; Simona Margarit; Delia Dima; Ciprian Tomuleasa
Journal:  J Pers Med       Date:  2022-04-23

3.  Lenalidomide-Associated Hemophagocytic Lymphohistiocytosis With Plasma Cell Phagocytosis.

Authors:  Elliot Runge; Chung-Ting J Kou; Matthew Rendo; David Lynch; Joshua Fenderson
Journal:  Cureus       Date:  2021-04-10

Review 4.  Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review.

Authors:  Fernanda Rodrigues Mendes; Karine Marques Sobral; Hebert Fabricio Culler; Samuel Campanelli Freitas Couto; Juliana Pereira; Vanderson Rocha; Gracia Aparecida Martinez; Luís Alberto de Pádua Covas Lage
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.